This post was written by John W. Mitchell and first appeared on DOTmed HealthCare Business Daily News. It has been reposted here with permission of the publisher. Having grown up in a town of population 1,600 in South Dakota, Todd
Axumin (18 Fluciclovine) is a radiopharmaceutical that is proving to be a game-changer, particularly in the field of prostate cancer detection. Axumin allows healthcare providers to image cellular activity and provides the best of both worlds for soft tissue and bone imaging.
There are common myths about mobile MRI and in this post we look at the facts to provide and honest comparistion of mobile vs. in-house services.
MRI technology has made some big advancements, leading to higher MRI magnet strength and clearer imaging. Does a bigger magnet always mean better? We explore what you really need in terms of field strength.
Interim imaging can be the answer to many of the challenges providers and hospitals face when it comes to managing their imaging needs. Successful execution of a short-term solution, however, begins in the planning stage. Here are some things you’ll